ACER - Acer Therapeutics CEO infuses $1M into company in exchange for promissory note
2023-06-26 12:39:40 ET
- Pharmaceutical company Acer Therapeutics ( NASDAQ: ACER ) said on Monday that CEO and Founder Christopher Schelling has infused $1M into the company in exchange for a promissory note.
- The company has issued a $1M unsecured, subordinated promissory note to Schelling, who currently owns more than 10% of the outstanding shares.
- The promissory note carries an interest rate of 6% per annum, and matures on Aug. 21.
- The funding is expected to be used to extend the company's cash runway into early Q3.
- Source: Press Release
For further details see:
Acer Therapeutics CEO infuses $1M into company in exchange for promissory note